RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$1.06
-0.08 (-7.02%)
Open$1.15
Previous Close$1.14
Day High$1.15
Day Low$1.06
52W High$3.87
52W Low$0.39
Volume—
Avg Volume1.01M
Market Cap139.75M
P/E Ratio—
EPS$-0.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+3,404.7% upside
Current
$1.06
$1.06
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.46M | 3.41M | 51.04M |
| Net Income | -130,375,190 | -89,748,868 | 8.38M |
| Profit Margin | -2,920.0% | -2,774.0% | 16.4% |
| EBITDA | -227,074,451 | -164,999,792 | 12.88M |
| Free Cash Flow | — | — | 6.14M |
| Rev Growth | +30.7% | +30.7% | +13.5% |
| Debt/Equity | 12.36 | 12.36 | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |